Core Viewpoint - Haisheng Medical (920166.BJ) experienced a significant drop in stock price, closing at 29.56 yuan, a decrease of 14.29% after its listing on the Beijing Stock Exchange on February 12 [1] Group 1: Company Overview - Haisheng Medical issued up to 11,294,118 shares to unspecified qualified investors at a price of 12.64 yuan per share, ensuring that public shareholders hold at least 25% post-issue [1] - The total amount raised from the issuance was 142,757,651.52 yuan, with a net amount of 113,438,208.84 yuan after expenses, which is 25,698.72 million yuan less than originally planned [1] - The company plans to use the raised funds for upgrading and expanding its anesthetic monitoring and emergency medical device production, R&D testing center projects, and marketing service base construction [1] Group 2: Financial Details - The total issuance costs amounted to 2,931.94 million yuan, including 500.00 million yuan for sponsorship fees and 900.00 million yuan for underwriting fees [1] - On February 12, the stock closed at 34.49 yuan, reflecting a substantial increase of 172.86% from its initial listing price [2]
海圣医疗上市第二个交易日跌14.29%